Plaintiff Nicholas Perusek filed a proposed securities class action against The Ensign Group on October 8, 2026, in the U.S. District Court for the Central District of California, case No. 8:26-cv-02963. The docket names the skilled-nursing and senior-living operator, along with CEO Barry R.
Port and CFO Suzanne D. Snapper, as defendants, and Laurence M. Rosen of Rosen Law Firm is listed as counsel of record for the plaintiff. The case covers investors who bought Ensign Group securities between February 10, 2022 and June 18, 2026, and alleges the company's public statements concealed regulatory and care-quality problems that surfaced in mid-2026. Investors who held shares during that window have a deadline to act if they want a say in how the case proceeds.
Official resource:
- Read the original report from Barchart — Use this primary source to review the complete report.
Table of Contents
- What the Lawsuit Claims
- The Short-Seller Reports Behind the Allegations
- Who Is Affected and What the Deadline Means
- Where the Case Stands Now
What the Lawsuit Claims
The complaint brings claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, covering the period from February 10, 2022 through June 18, 2026, according to a Robbins Geller Rudman & Dowd LLP notice. Those sections of federal securities law let investors sue a company and its executives when public statements are allegedly misleading and someone acting on those statements loses money.
The core allegation is that Ensign's statements understated regulatory and care-quality risk at its facilities, leaving out problems with understaffing, improper billing, and resident care, according to a Bleichmar Fonti & Auld LLP notice. Two short-seller reports published in June 2026 are central to the case, since they're what the lawsuit says exposed the gap between what Ensign told investors and what was actually happening inside its facilities.
The Short-Seller Reports Behind the Allegations
On June 8, 2026, Hunterbrook published a report alleging Ensign manipulated its Medicare quality-star ratings and engaged in improper related-party billing. The report directly disputed CEO Barry Port's claim on a May 1, 2026 earnings call that 85% of Ensign's operations held a 4- or 5-star quality rating, according to a Pomerantz LLP investor alert. Ensign shares fell 8.15%, or $13.88, closing at $156.42 that day.
Three days later, on June 11, 2026, Muddy Waters Research published a second report alleging that Ensign facilities rented out administrator licenses to people who weren't actually running the facilities, a practice it said could amount to Medicare and Medicaid fraud under the False Claims Act, according to The Bear Cave newsletter. Shares fell a further 2.98%, or $4.52, closing at $147.13 that day. Together, the two reports knocked Ensign stock down more than 11% in under a week. That drop is the financial injury the lawsuit is built around, since securities fraud claims require investors to show they lost money after relying on allegedly misleading statements.
Who Is Affected and What the Deadline Means
Anyone who bought Ensign Group (NASDAQ: ENSG) stock between February 10, 2022 and June 18, 2026 falls within the proposed class. The December 7, 2026 lead-plaintiff deadline comes from the Private Securities Litigation Reform Act (PSLRA), which gives investors 60 days after a complaint is filed to ask the court to serve as lead plaintiff, according to the Robbins Geller notice.
Being the lead plaintiff means directing the litigation on behalf of the whole class, typically alongside counsel the court approves to represent the group. Missing the December 7 deadline doesn't remove an investor from the class or forfeit any eventual recovery — it only forfeits the chance to steer the case as lead plaintiff, a role most class members never seek.
- Bought ENSG shares between February 10, 2022 and June 18, 2026: potentially part of the class
- Want to seek lead plaintiff status: must act by December 7, 2026
- Not seeking lead plaintiff status: no action required to stay in the class if one is later certified
- Sold shares before February 10, 2022 or bought only after June 18, 2026: outside the alleged class period
Where the Case Stands Now
As of mid-October 2026, no class has been certified, and Ensign has not filed a public response to the allegations, according to the case docket. That means the claims against the company, Port, and Snapper remain allegations, not findings — the case is at the earliest stage of federal litigation.
Multiple firms, including Rosen Law Firm, Robbins Geller, Bleichmar Fonti & Auld, and Pomerantz, have filed or publicized interest in the case, which is common when a stock drop of this size draws scrutiny from several plaintiffs' firms at once. Courts typically consolidate related filings and appoint a single lead plaintiff and lead counsel to avoid duplicate litigation over the same facts. For investors tracking the case, the practical next milestones are the December 7 lead-plaintiff deadline, followed by the court's appointment of lead plaintiff and counsel, and then any motion by Ensign to dismiss the complaint — the point at which the company's formal response to the allegations would typically appear on the docket.